Extended perfusion defects in lung perfusion-SPECT/CT in a case of fatal COVID-19 pneumonia

Introduction

A number of publications describe coagulopathy as a sequela of infection with the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), also known as COVID-19 [1]. Although the exact nature of the relationship between severe SARS-CoV-2 infection and thromboembolic disease is yet to be fully clarified [2] the importance of CT-angiography [3] and SPECT/CT to exclude pulmonary embolus (PE) are increasingly recognised [4].

Publikationsverlauf

Artikel online veröffentlicht:
26. Januar 2021

• References

• 1 Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology 2020; 127: 104362
• 2 Danzi GB, Loffi M, Galeazzi G. et al. Acute pulmonary embolism and COVID-19 pneumonia: a random association?. European Heart Journal 2020; 41 (19) 1858
• 3 Poyiadji N, Cormier P, Patel PY. et al. Acute Pulmonary Embolism and COVID-19. Radiology 2020; 297 (03) E335-E338
• 4 Zuckier LS, Moadel RM, Haramati LB. et al. Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic. Journal of Nuclear Medicine 2020; 61 (05) 630-631
• 5 Cobes N, Guernou M, Lussato D. et al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. European journal of nuclear medicine and molecular imaging 2020; 47 (10) 2453-2460